BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6894630)

  • 1. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol.
    Llach F; Felsenfeld AJ; Haussler MR
    N Engl J Med; 1981 Jul; 305(3):117-23. PubMed ID: 6894630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium metabolism in acute renal failure due to rhabdomyolysis.
    Hadjis T; Grieff M; Lockhat D; Kaye M
    Clin Nephrol; 1993 Jan; 39(1):22-7. PubMed ID: 8428403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone and 25-hydroxycholecalciferol levels in hypercalcemia of acute renal failure.
    Weinstein RS; Hudson JB
    Arch Intern Med; 1980 Mar; 140(3):410-1. PubMed ID: 7362360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum calcium derangements in rhabdomyolysis.
    Knochel JP
    N Engl J Med; 1981 Jul; 305(3):161-3. PubMed ID: 6894631
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of parathyroid hormone and 1,25 dihydroxycholecalciferol in calcium homeostasis of rhabdomyolysis.
    Motellón JL; Bernis C; Gruss E; Traver JA
    Nephrol Dial Transplant; 1995; 10(2):299-300. PubMed ID: 7753474
    [No Abstract]   [Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of acute renal failure in rhabdomyolysis caused by alcohol and drug intoxication].
    Kárpáti I; Kurta G; Mátyas J; Ujhelyi L; Kakuk G
    Orv Hetil; 1990 May; 131(21):1147-50. PubMed ID: 2194151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hypercalcemia with acute renal failure associated with nontraumatic rhabdomyolysis.
    Feinstein EI; Akmal M; Telfer N; Massry SG
    Arch Intern Med; 1981 May; 141(6):753-5. PubMed ID: 6972199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure.
    Akmal M; Bishop JE; Telfer N; Norman AW; Massry SG
    J Clin Endocrinol Metab; 1986 Jul; 63(1):137-42. PubMed ID: 3011837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and hypocalcemia in man.
    Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
    J Clin Endocrinol Metab; 1980 Mar; 50(3):480-4. PubMed ID: 6892641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
    Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
    J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of vitamin D metabolites in patients with hyperinsulinaemia.
    Ishida H; Seino Y; Tsuda K; Matsukura S; Miyamoto Y; Ishizuka S; Imura H
    Hum Nutr Clin Nutr; 1984 Nov; 38(6):473-5. PubMed ID: 6549179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone.
    Metz SA; Baylink DJ; Hughes MR; Haussler MR; Robertson RP
    N Engl J Med; 1977 Nov; 297(20):1084-90. PubMed ID: 198661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
    Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
    Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia in association with acute renal failure and rhabdomyolysis. Case report and literature review.
    Meneghini LF; Oster JR; Camacho JR; Gkonos PJ; Roos BA
    Miner Electrolyte Metab; 1993; 19(1):1-16. PubMed ID: 8345829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid adenoma causing persistent hypercalcaemia after rhabdomyolysis-induced acute renal failure.
    Goldman M; Kinnaert P; Fuss M; Abramowicz M; Van Geertruyden J; Toussaint C
    Nephrol Dial Transplant; 1986; 1(1):50-2. PubMed ID: 3110663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
    Chesney RW; Hamstra A; Rose P; DeLuca HF
    Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma 1,25 hydroxycholecalciferol concentrations and net intestinal calcium, phosphate and magnesium absorption in man.
    Ruggiero M; Brunese M; Morelli S; Salvia PF; Mangoni C; Stefano S
    Boll Soc Ital Biol Sper; 1981 Apr; 57(7):791-7. PubMed ID: 6895034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcemic response to magnesium or 1-alpha-hydroxycholecalciferol treatment in intestinal hypomagnesemia.
    Ducreux M; Messing B; De Vernejoul MC; Bouhnik Y; Miravet L; Rambaud JC
    Gastroenterol Clin Biol; 1991; 15(11):805-11. PubMed ID: 1663053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased 1,25-dihydroxycholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis.
    Koide Y; Kugai N; Kimura S; Fujita T; Yamashita N; Hiramoto ; Sukegawa J; Ogata E; Yamashita K
    J Clin Endocrinol Metab; 1981 Mar; 52(3):494-8. PubMed ID: 6257749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.